March 22, 2023
AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
January 19, 2023
AbCellera Announces that the U.S. Patent Trial and Appeal Board Upholds Microfluidic Cell Culture Patent
December 15, 2022
AbCellera and AbbVie Partner to Advance New Antibody Therapies
No current content.
Connect with us LinkedIn